iguratimod has been researched along with Leukemia, Acute Monocytic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aikawa, Y; Morimoto, K; Tanaka, K; Yamamoto, M; Yamamoto, T | 1 |
1 other study(ies) available for iguratimod and Leukemia, Acute Monocytic
Article | Year |
---|---|
An anti-rheumatic agent T-614 inhibits NF-kappaB activation in LPS- and TNF-alpha-stimulated THP-1 cells without interfering with IkappaBalpha degradation.
Topics: Antirheumatic Agents; Benzopyrans; Biotransformation; Blotting, Western; Cell Nucleus; Cytokines; Electrophoresis; Enzyme-Linked Immunosorbent Assay; Humans; I-kappa B Proteins; Interleukin-6; Interleukin-8; Leukemia, Monocytic, Acute; Lipopolysaccharides; NF-kappa B; NF-KappaB Inhibitor alpha; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |